Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 11 2020
revised: 22 04 2021
accepted: 04 05 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Cancer/tumor cells infected with the "avian paramyxovirus Newcastle Disease Virus (TC-NDV)" express the viral hemagglutinin-neuraminidase (HN) on the cell surface that is used as both the danger signal and anchor for bi/tri-specific antibodies (bs/tsAbs).We constructed a bs-Ab (HN-Fc-CD16) that bindsto HN and natural killer (NK)-CD16 receptor (FcgRIII)and a ts-Ab (HN-Fc-IL15-CD16) harbouring NK-activating cytokine "IL-15" within the bs-Ab.In silicoand computational predictions indicated proper exposure of both Abs in bs/tsAbs.Properbinding of thebi/tsAbstoHN on surface of TC-NDVandCD16

Identifiants

pubmed: 34162140
pii: S1567-5769(21)00398-2
doi: 10.1016/j.intimp.2021.107762
pii:
doi:

Substances chimiques

Antibodies, Bispecific 0
Antineoplastic Agents, Immunological 0
HN Protein 0
Immunoglobulin Fc Fragments 0
Ligands 0
Receptors, IgG 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107762

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Mina Bahrololoumi Shapourabadi (M)

Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: minabahrololoumi@gmail.com.

Frank Momburg (F)

Antigen Presentation & T/NK Cell Unit, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: f.momburg@dkfz-heidelberg.de.

Farzin Roohvand (F)

Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: rfarzin@pasteur.ac.ir.

Mostafa Jarahian (M)

Antigen Presentation & T/NK Cell Unit, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: mostafajarahian@gmail.com.

Nasir Mohajel (N)

Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: n_mohajel@pasteur.ac.ir.

Arash Arashkia (A)

Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: a_arashkia@pasteur.ac.ir.

Fatemeh Hajari Taheri (F)

Department of Immunology, Hybridoma Lab, Pasteur Institute of Iran, Tehran, Iran. Electronic address: f.h.taheri@gmail.com.

Maryam Abbasalipour (M)

Department of Molecular Medicine, Biotechnology Research Centre, Pasteur Institute of Iran, Tehran, Iran. Electronic address: m.abbasalipour@gmail.com.

Kayhan Azadmanesh (K)

Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: azadmanesh@pasteur.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH